Clinical Trial Update: Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 safety and PK/PD study of TG-0054 in patients with multiple myeloma, non-Hodgkin lymphoma, and Hodgkin disease has completed with results posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• TG-0054

Snippet

Sponsor: GPCR Therapeutics, Inc. | Conditions: Multiple Myeloma, Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-01-15